Antitumor agent-180
Product Specifications
Target
Apoptosis
Related Pathways
Apoptosis
Bioactivity
Antitumor agent-180 (Compound 13a) is an inhibitor of BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) . It suppresses the proliferation of ccRCC cells Caki-1 with an IC50 of 2.047 µM and induces necrosis and apoptosis in Caki-1 cells.
Molecular Formula
C34H41N9O
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6004116-01 0.2 mL
GPRC5B, CT (GPRC5B, RAIG2, G-protein coupled receptor family C group 5 member B, A-69G12.1, Retinoic acid-induced gene 2 protein)
Ask
View Details MBS6004116-02 5x 0.2 mL
GPRC5B, CT (GPRC5B, RAIG2, G-protein coupled receptor family C group 5 member B, A-69G12.1, Retinoic acid-induced gene 2 protein)
Ask
View Details 